You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 20190418042451f2bbe32a
conjunctiva
Oops, an error occurred! Code: 2019041804245114760a94
disease gene mapping
Oops, an error occurred! Code: 20190418042451f71fb9ee
gene/expression
Oops, an error occurred! Code: 20190418042451f62c2acd
gene microarray
Oops, an error occurred! Code: 2019041804245197888c8d
genetics
Oops, an error occurred! Code: 2019041804245158b403a4
immunohistochemistry
Oops, an error occurred! Code: 20190418042451fc6573d0
iris
Oops, an error occurred! Code: 20190418042451602b1342
melanoma
Oops, an error occurred! Code: 201904180424517114b0f4
oncology
Oops, an error occurred! Code: 20190418042451e7f7dacb
pathology: experimental
Oops, an error occurred! Code: 20190418042451a2d8371e
pathology: human
Oops, an error occurred! Code: 20190418042451c79f58f0
pathology techniques
Oops, an error occurred! Code: 2019041804245104cffaf1
tumors
Oops, an error occurred! Code: 20190418042451964c540c
uvea
Oops, an error occurred! Code: 20190418042451936b988c
vision and action
Oops, an error occurred! Code: 20190418042451331edb81
visual acuity
Oops, an error occurred! Code: 20190418042451f9fd71aa
uveal melanoma
Oops, an error occurred! Code: 2019041804245198c78cc4
conjunctival melanoma
Oops, an error occurred! Code: 201904180424516b2588ac
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 201904180424516d3bb1cc
pathology
Oops, an error occurred! Code: 20190418042451c12ff051
translational studies
Oops, an error occurred! Code: 20190418042451483c57c2